Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.80T | 2.54T | 1.21T | 1.02T | 936.66B | 791.75B | Gross Profit |
2.80T | 2.54T | 1.21T | 1.02T | 936.66B | 791.75B | EBIT |
1.67T | 1.02T | 661.56B | 518.56B | 439.80B | 365.75B | EBITDA |
501.01B | 1.05T | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
695.80B | 640.62B | 495.45B | 386.00B | 325.98B | 260.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.29T | 7.15T | 7.24T | 5.99T | 5.32T | 4.13T | Total Assets |
40.30T | 44.12T | 25.76T | 21.11T | 17.98T | 15.96T | Total Debt |
7.31T | 8.09T | 3.24T | 2.19T | 1.48T | 1.47T | Net Debt |
5.02T | 4.67T | 878.07B | 587.42B | 443.06B | 742.81B | Total Liabilities |
7.31T | 36.23T | 22.84T | 18.60T | 15.82T | 14.07T | Stockholders Equity |
4.56T | 4.56T | 2.91T | 2.50T | 2.16T | 1.89T |
Cash Flow | Free Cash Flow | ||||
0.00 | 147.83B | 433.58B | 554.69B | 903.97B | 152.89B | Operating Cash Flow |
0.00 | 190.69B | 477.20B | 581.02B | 921.78B | 171.18B | Investing Cash Flow |
0.00 | -3.67T | -4.39T | -3.30T | -2.52T | -2.15T | Financing Cash Flow |
0.00 | 3.35T | 4.17T | 2.91T | 1.92T | 1.85T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $208.17B | 11.02 | 10.83% | 5.47% | -1.91% | -6.79% | |
78 Outperform | $247.51B | 13.67 | 11.05% | 2.05% | 3.51% | 16.51% | |
77 Outperform | $120.69B | 20.02 | 17.89% | 0.59% | 22.15% | 12.13% | |
73 Outperform | $173.48B | 22.40 | 14.51% | 0.81% | 13.13% | 0.54% | |
65 Neutral | $154.55B | 13.10 | 9.18% | 1.72% | 13.21% | -12.06% | |
64 Neutral | $142.19B | 12.03 | 6.30% | 2.91% | 2.97% | 87.82% | |
64 Neutral | $12.78B | 9.87 | 7.67% | 17015.06% | 12.34% | -5.99% |